Compare KULR & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KULR | SERA |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Precision Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.1M | 75.2M |
| IPO Year | 2016 | 2021 |
| Metric | KULR | SERA |
|---|---|---|
| Price | $1.66 | $1.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | ★ 746.4K | 16.2K |
| Earning Date | 11-13-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,274,028.00 | $81,000.00 |
| Revenue This Year | N/A | $177.78 |
| Revenue Next Year | $101.34 | $755.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $1.50 | $1.56 |
| 52 Week High | $5.43 | $3.85 |
| Indicator | KULR | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 33.22 | 43.21 |
| Support Level | $1.50 | $1.91 |
| Resistance Level | $2.72 | $2.03 |
| Average True Range (ATR) | 0.11 | 0.05 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 31.15 | 15.38 |
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices. The Company operated two segments -EMP and Mining of Digital Assets.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.